Technologies to Tools grant
Validating CRISPR-engineered human pluripotent stem cell-derived cardiomyocytes as tools to assist with toxicity profiling, adverse drug reaction notices and black box warnings
![Test tubes](/sites/default/files/styles/right_column_image/public/2021-08/from%20Walmsley%204.jpg?itok=-6j6NS54)
At a glance
Completed
Award date
February 2020 - December 2021
Grant amount
£49,996
Principal investigator
Professor Chris Denning
Co-investigator(s)
Institute
University of Nottingham
R
- Replacement